MarcILorberMDFACS
General Surgery • New Haven, CTTransplantation
CMO & SVP Lung Biotechnology PBC, United Therapeutics Corporation
Dr. Lorber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Howard Ave
# Yale
New Haven, CT 06519Phone+1 203-785-2140Fax+1 203-785-6414
Education & Training
University of MichiganResidency, Surgery, 1977 - 1984
Rush Medical College of Rush University Medical CenterClass of 1977
Certifications & Licensure
CT State Medical License 1986 - 2025
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 223 citationsGenetically Modified Porcine-to-Human Cardiac Xenotransplantation.Bartley P Griffith, Corbin E Goerlich, Avneesh K Singh, Martine Rothblatt, Christine L Lau
The New England Journal of Medicine. 2022-07-07 - 2 citationsThe role of industry in advancing xenotransplantation.Jordan T Shin, Martine A Rothblatt, Marc I. Lorber
Current Opinion in Organ Transplantation. 2019-10-01 - Intra-bone bone marrow transplantation from hCD47 transgenic pigs to baboons prolongs chimerism to >60 days and promotes increased porcine lung transplant survival.Hironosuke Watanabe, Yuichi Ariyoshi, Thomas Pomposelli, Kazuhiro Takeuchi, Dilrukshi K Ekanayake-Alper
Xenotransplantation. 2019-09-24
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
